ROSIGLITAZONE, AN AGONIST OF PEROXISOME-PROLIFERATOR ACTIVATED RECEPTOR-GAMMA, AMELIORATES CISPLATIN NEPHROTOXICITY THROUGH THE INHIBITION OF TNF-α/NF-κB ACTIVATION

被引：0
|
作者：
Park, Sung-Kwang [1 ]
Lee, Sik [1 ]
Kim, Won [1 ]
Moon, Sang-Ok [1 ]
Sung, Mi Jeong [1 ]
Kim, Duk Hoon [1 ]
Kang, Kyung Pyo [1 ]
Kang, Sung Kyew [1 ]
机构：
[1] Chonbuk Natl Univ, Sch Med, Dept Internal Med, Renal Regenerat Lab,Res Inst Clin Med, Chonju, South Korea
来源：
NEPHROLOGY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A278 / A278
页数：1
相关论文
共 50 条
  • [1] Rosiglitazone, peroxisome proliferator receptor-gamma agonist, ameliorates gentamicin-induced nephrotoxicity in rats
    Ozbek, Emin
    Ilbey, Yusuf Ozlem
    Simsek, Abdulmuttalip
    Cekmen, Mustafa
    Mete, Fatih
    Somay, Adnan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2010, 42 (03) : 579 - 587
  • [2] Rosiglitazone, peroxisome proliferator receptor-gamma agonist, ameliorates gentamicin-induced nephrotoxicity in rats
    Emin Ozbek
    Yusuf Ozlem Ilbey
    Abdulmuttalip Simsek
    Mustafa Cekmen
    Fatih Mete
    Adnan Somay
    International Urology and Nephrology, 2010, 42 : 579 - 587
  • [3] Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone ameliorates postoperative pain by regulating macrophage polarization
    Godai, Kohei
    Hasegawa-Moriyama, Maiko
    Ohnou, Tetsuya
    Kanmura, Yuichi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 188P - 188P
  • [4] Activation of peroxisome-proliferator activated receptor-gamma (PPARγ) is associated with changes in NF-κB activity and Bcl-2 expression in human colon cancer
    Chen, GG
    Lee, FYJ
    Wang, SH
    Chan, UPF
    Ip, PC
    Lau, WYJ
    GASTROENTEROLOGY, 2001, 120 (05) : A667 - A667
  • [5] Effects of peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, on chemoprevention of gastric cancer in rat
    Leung, Wai K.
    Liao, Shanying
    Zeng, Zhi-Rong
    Wong, Christine Y.
    Chu, Wai-Kit
    Cheng, Victoria Y.
    To, Ka-Fai
    Yu, Jun
    Hu, Pin-Jin
    Sung, Joseph J.
    GASTROENTEROLOGY, 2006, 130 (04) : A9 - A9
  • [6] Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces the size of experimental endometriosis in the rat model
    Aytan, Hakan
    Caliskan, Ahmet C.
    Demirturk, Fazli
    Aytan, Pelin
    Koseoglu, Dogan R.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2007, 47 (04): : 321 - 325
  • [7] Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates postincisional pain by regulating macrophage polarization
    Hasegawa-Moriyama, Maiko
    Ohnou, Tetsuya
    Godai, Kohei
    Kurimoto, Tae
    Nakama, Mayo
    Kanmura, Yuichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 426 (01) : 76 - 82
  • [8] Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and Nf-kB in human colon cancer
    Chen, GG
    Lee, JFY
    Wang, SH
    Chan, UPF
    Ip, PC
    Lau, WY
    LIFE SCIENCES, 2002, 70 (22) : 2631 - 2646
  • [9] Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis
    Yun-Fang Zhang
    Xun-Liang Zou
    Jun WU
    Xue-Qing Yu
    Xiao Yang
    Inflammation, 2015, 38 : 2105 - 2115
  • [10] Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis
    Zhang, Yun-Fang
    Zou, Xun-Liang
    Wu, Jun
    Yu, Xue-Qing
    Yang, Xiao
    INFLAMMATION, 2015, 38 (06) : 2105 - 2115
12345